Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07739719) titled 'SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)' on July 28.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: McMaster University

Condition: Influenza (Healthy Volunteers)

Intervention: Biological: LAIV FLUMIST

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: October 15, 2026

Target Sample Size: 966

Countries of Recruitment: Canada

To know more, visit https://clinicaltrials.gov/study/NCT07739719...